Improvement in night sleep duration and the effect on diabetes in pregnancy
- Conditions
- Glucose tolerance in pregnancyPregnancy and Childbirth
- Registration Number
- ISRCTN17526076
- Lead Sponsor
- niversity Malaya Medical Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 240
1. Self-reported sleep less than 7 hours
2. Gestation less than 34 weeks
3. Singleton pregnancy
4. Aged 18 to 40 years old
1. Inability to use eye mask and earplugs
2. Inability to use ActiGraph wGT3X-BT device
3. Pre-existing sleep disorders: chronic insomnia, sleep apnea
4. Pre-existing psychiatric disorders: depression, schizophrenia etc
5. Pre-existing medical disorders: diabetic mellitus, systemic lupus erythematosus, thyroid disorders, epilepsy, heart diseases etc
6. Active smoker
7. Current alcohol consumption
8. Multipara with co-sleeping child/children
9. Night shift workers
10. Night care-taker of other family members
11. Gross fetal anomalies
12. Intrauterine fatal death
13. Body mass index (BMI) =35 kg/m²
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Night sleep duration measured using the Actigraph wGT3X-BT device at the end of week 1<br>2. Fasting blood sugar and 2-hour post glucose tolerance test measured using oral glucose tolerance test performed at the end of week 1
- Secondary Outcome Measures
Name Time Method 1. Actigraphy-derived Wake After Sleep Onset (WASO) and actigraphy-derived sleep efficiency measured using the Actigraph wGT3X-BT device at the end of week 1 <br>2. Sleep satisfaction measured using the Pittsburgh Sleep Quality Index (PSQI) during recruitment, and the modified Pittsburgh Sleep Quality Index at the end of week 1